Repositioning of a cyclin-dependent kinase inhibitor GW8510 as a ribonucleotide reductase M2 inhibitor to treat human colorectal cancer

por Hsieh, Y-Y, Chou, C-J, Lo, H-L, Yang, P-M
Publicado 2016

Six weeks' sebacic acid supplementation improves fasting plasma glucose, HbA1c and glucose tolerance in db/db mice

por Membrez, M, Chou, C J, Raymond, F, Mansourian, R, Moser, M, Monnard, I, Ammon-Zufferey, C, Mace, K, Mingrone, G, Binnert, C
Publicado 2010